Search research articles
Contact Us
Filters
Showing results (101-110 of 178) with videos related to
Page
of 18
Sort By:
Journal of the American College of Cardiology
|
March 27, 2024
Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid
Fatima Rodriguez, Leslie Cho, JoAnne Foody, et al.
Atherosclerosis
|
October 7, 2016
Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN
Brian Stegman, Mingyuan Shao, Stephen J Nicholls, et al.
The American Journal of Cardiology
|
September 18, 2023
Use of Coronary Artery Calcium Quantification and Distribution for Coronary Vascular Disease Risk Reclassification in a Primary Prevention Setting
Adel Hajj Ali, Michael Nakhla, Leslie Cho, et al.
Cardiovascular Drugs and Therapy
|
March 4, 2016
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study
Leslie Cho, Michael Rocco, David Colquhoun, et al.
Open Heart
|
November 24, 2021
CHA<sub>2</sub>DS<sub>2</sub>-VASc score stratifies mortality risk in patients with and without atrial fibrillation
Serge C Harb, Tom Kai Ming Wang, David Nemer, et al.
Cardiovascular Diagnosis and Therapy
|
July 6, 2019
Reclassification of coronary heart disease risk in a primary prevention setting: traditional risk factor assessment <i>vs</i>. coronary artery calcium scoring
Alaa Alashi, Richard Lang, Raul Seballos, et al.
Circulation. Heart Failure
|
January 22, 2021
Exercise Ventricular Rates, Cardiopulmonary Exercise Performance, and Mortality in Patients With Heart Failure With Atrial Fibrillation
Mohamed B Elshazly, Bruce L Wilkoff, Khaldoun Tarakji, et al.
Journal of Clinical Lipidology
|
April 25, 2026
Identifying severe hypercholesterolemia in participants of ASCVD trials: Implications for trial conduct and opportunistic screening
Abhayjit Singh, Julie St John, Luke Laffin, et al.
The American Journal of Cardiology
|
June 14, 2008
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease
Mehdi H Shishehbor, Leonardo P J Oliveira, Michael S Lauer, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2019
Risk for Anaphylactic Reaction from Cardiac Catheterization in Patients Receiving β-Adrenergic Blockers or Angiotensin-Converting Enzyme-Inhibitors
Martin A Smith, Lisanne P Newton, Maria A Barcena Blanch, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 178) with videos related to
Sort By:
Page
of 18
Journal of the American College of Cardiology
|
March 27, 2024
Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid
Fatima Rodriguez, Leslie Cho, JoAnne Foody, et al.
Atherosclerosis
|
October 7, 2016
Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN
Brian Stegman, Mingyuan Shao, Stephen J Nicholls, et al.
The American Journal of Cardiology
|
September 18, 2023
Use of Coronary Artery Calcium Quantification and Distribution for Coronary Vascular Disease Risk Reclassification in a Primary Prevention Setting
Adel Hajj Ali, Michael Nakhla, Leslie Cho, et al.
Cardiovascular Drugs and Therapy
|
March 4, 2016
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study
Leslie Cho, Michael Rocco, David Colquhoun, et al.
Open Heart
|
November 24, 2021
CHA<sub>2</sub>DS<sub>2</sub>-VASc score stratifies mortality risk in patients with and without atrial fibrillation
Serge C Harb, Tom Kai Ming Wang, David Nemer, et al.
Cardiovascular Diagnosis and Therapy
|
July 6, 2019
Reclassification of coronary heart disease risk in a primary prevention setting: traditional risk factor assessment <i>vs</i>. coronary artery calcium scoring
Alaa Alashi, Richard Lang, Raul Seballos, et al.
Circulation. Heart Failure
|
January 22, 2021
Exercise Ventricular Rates, Cardiopulmonary Exercise Performance, and Mortality in Patients With Heart Failure With Atrial Fibrillation
Mohamed B Elshazly, Bruce L Wilkoff, Khaldoun Tarakji, et al.
Journal of Clinical Lipidology
|
April 25, 2026
Identifying severe hypercholesterolemia in participants of ASCVD trials: Implications for trial conduct and opportunistic screening
Abhayjit Singh, Julie St John, Luke Laffin, et al.
The American Journal of Cardiology
|
June 14, 2008
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease
Mehdi H Shishehbor, Leonardo P J Oliveira, Michael S Lauer, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2019
Risk for Anaphylactic Reaction from Cardiac Catheterization in Patients Receiving β-Adrenergic Blockers or Angiotensin-Converting Enzyme-Inhibitors
Martin A Smith, Lisanne P Newton, Maria A Barcena Blanch, et al.
Page
of 18